BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

862 related articles for article (PubMed ID: 14679922)

  • 1. [Fungal infections in transplantation patients].
    Colomba C; Antinori S
    Recenti Prog Med; 2003 Nov; 94(11):516-28. PubMed ID: 14679922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungal infections in solid organ transplant recipients.
    Hadley S; Karchmer AW
    Infect Dis Clin North Am; 1995 Dec; 9(4):1045-74. PubMed ID: 8747778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fungal infections in patients undergoing bone marrow transplantation: an approach to a rational management protocol.
    Castagnola E; Bucci B; Montinaro E; Viscoli C
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():97-106. PubMed ID: 8932808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic antifungal agents used after lung transplantation.
    Marino E; Gallagher JC
    Ann Pharmacother; 2010 Mar; 44(3):546-56. PubMed ID: 20179260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungal infections after lung transplantation.
    Solé A; Salavert M
    Transplant Rev (Orlando); 2008 Apr; 22(2):89-104. PubMed ID: 18631862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
    Salavert M
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S149-53. PubMed ID: 19013340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation.
    Shi SH; Lu AW; Shen Y; Jia CK; Wang WL; Xie HY; Zhang M; Liang TB; Zheng SS
    Chin Med J (Engl); 2008 Apr; 121(7):625-30. PubMed ID: 18466683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fungal infections in solid organ transplantation.
    Silveira FP; Husain S
    Med Mycol; 2007 Jun; 45(4):305-20. PubMed ID: 17510855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of anidulafungin in solid organ transplant recipients].
    Aguado JM; Ayats J
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():29-34. PubMed ID: 19572432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Candidiasis, aspergillosis and other invasive mycoses in recipients of solid organ transplants].
    Quindós G
    Rev Iberoam Micol; 2011; 28(3):110-9. PubMed ID: 21700230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aspergillosis in pulmonary transplantation].
    de Pablo A; Ussetti P; Cruz Carreño M; Lázaro T; Ferreiro MJ; López A; Mendaza P; Estada J
    Enferm Infecc Microbiol Clin; 2000 May; 18(5):209-14. PubMed ID: 10974763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fungal infections in patients undergoing solid organ transplantation].
    Muñoz P; Bouza E
    Enferm Infecc Microbiol Clin; 1997 May; 15 Suppl 2():34-50. PubMed ID: 9312298
    [No Abstract]   [Full Text] [Related]  

  • 14. [Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update].
    Fortún J; Carratalá J; Gavaldá J; Lizasoain M; Salavert M; de la Cámara R; Borges M; Cervera C; Garnacho J; Lassaleta Á; Lumbreras C; Sanz MÁ; Ramos JT; Torre-Cisneros J; Aguado JM; Cuenca-Estrella M;
    Enferm Infecc Microbiol Clin; 2011; 29(6):435-54. PubMed ID: 21474210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation.
    Martin T; Sharma M; Damon L; Kaplan L; Guglielmo BJ; Working M; O'Malley R; Hwang J; Linker C
    Transpl Infect Dis; 2010 Feb; 12(1):45-50. PubMed ID: 19793068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The place for itraconazole in treatment.
    Maertens J; Boogaerts M
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i33-i38. PubMed ID: 16120632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.
    Husain S; Alexander BD; Munoz P; Avery RK; Houston S; Pruett T; Jacobs R; Dominguez EA; Tollemar JG; Baumgarten K; Yu CM; Wagener MM; Linden P; Kusne S; Singh N
    Clin Infect Dis; 2003 Jul; 37(2):221-9. PubMed ID: 12856215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
    Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of liposomal amphotericin B for the prophylaxis of fungal infection in solid organ transplant recipients].
    López-Medrano F; Díaz-Pedroche C; Lumbreras C; Aguado JM
    Rev Esp Quimioter; 2005 Mar; 18(1):14-20. PubMed ID: 15915227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress?
    Jantunen E; Anttila VJ; Ruutu T
    Bone Marrow Transplant; 2002 Dec; 30(12):925-9. PubMed ID: 12476286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.